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Abstract
Gap junctions consist of arrays of intercellular channels that enable adjacent cells to communicate both electrically and 
metabolically. Gap junctions have a wide diversity of physiological functions, playing critical roles in both excitable and 
non-excitable tissues. Gap junction channels are formed by integral membrane proteins called connexins. Inherited or 
acquired alterations in connexins are associated with numerous diseases, including heart failure, neuropathologies, deafness, 
skin disorders, cataracts and cancer. Gap junctions are highly dynamic structures and by modulating the turnover rate of 
connexins, cells can rapidly alter the number of gap junction channels at the plasma membrane in response to extracellular 
or intracellular cues. Increasing evidence suggests that ubiquitination has important roles in the regulation of endoplasmic 
reticulum-associated degradation of connexins as well as in the modulation of gap junction endocytosis and post-endocytic 
sorting of connexins to lysosomes. In recent years, researchers have also started to provide insights into the physiological 
roles of connexin ubiquitination in specific tissue types. This review provides an overview of the advances made in under-
standing the roles of connexin ubiquitination in the regulation of gap junction intercellular communication and discusses 
the emerging physiological and pathophysiological implications of these processes.
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Introduction
Gap junctions are plasma membrane domains containing 
arrays of intercellular channels that allow for the direct 
transfer of ions and small molecules (< ~ 1.2 kDa) between 
cells [1]. In vertebrates, gap junction channels are formed 
by a family of transmembrane proteins called connexins, 
which in humans constitutes 20 members [2]. Connexins 
are expressed in almost all cell types of the human body and 
have essential roles during development as well as in the 
adult organism. In providing a pathway for electrical com-
munication, gap junctions are fundamental to the function of 
excitable cells, such as neurons, cardiomyocytes and smooth 
muscle cells [3]. Moreover, by enabling the intercellular 
exchange of small metabolites and second messengers, gap 
junctions have a plethora of essential roles in non-excitable 
tissues, including the regulation of cell proliferation and dif-
ferentiation and the maintenance of tissue homeostasis [4, 
5]. There is also increasing evidence that connexins have 
important cell physiological functions that go beyond their 
ability to form canonical gap junctions. For instance, recent 
studies have demonstrated that connexins are involved in 
cell–cell communication via tunneling nanotubes and extra-
cellular vesicles [6]. Moreover, connexin-based channels 
at the plasma membrane that are not assembled into gap 
junctions, also known as hemichannels, have central roles 
in autocrine and paracrine signaling by providing a pathway 
for the exchange of ions and small molecules between the 
intracellular and extracellular milieus [7]. In addition, the 
intracellular domains of connexins can interact with other 
proteins, including components of the cytoskeleton, such as 
tubulin, and cell signaling pathways, such as cyclin E and 
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β-catenin [8–11]. Through such protein–protein interactions, 
connexins can modulate cell growth, differentiation, migra-
tion and other cellular processes in channel-independent 
manners. The multifaceted roles of connexins in human 
physiology are reflected by the fact that inherited or acquired 
alterations in connexins are associated with numerous dis-
eases, including heart failure, neuropathologies, deafness, 
skin disorders, cataracts and cancer [12–14]. Obtaining a 
better understanding of the molecular basis underlying the 
loss of connexin function in disease pathogenesis may have 
important therapeutic implications [15–17].
The connexin pool that constitutes gap junctions is con-
tinuously replaced due to the formation of new intercellular 
channels at their edges and the removal of old channels from 
their center by endocytosis and subsequent degradation in 
lysosomes [18–22]. This dynamic nature of gap junctions 
is reflected by the observation that the connexins have a 
high turnover rate in most tissue types, typically display-
ing half-lives of 1.5-5 h [23–25]. Substantial evidence sug-
gests that cells can modulate the connexin degradation rate 
in response to various extracellular or intracellular cues to 
alter the number of functional gap junction channels at the 
plasma membrane [20, 26–32].
An increasing body of experimental work suggests that 
post-translational modification of connexins by ubiquitina-
tion has an important role in regulating the level of gap junc-
tion intercellular communication. Ubiquitination has been 
suggested to be involved in controlling the degradation of de 
novo synthesized connexins at the endoplasmic reticulum, in 
modulating the rate of gap junction endocytosis, and in sort-
ing connexins to lysosomes via either the autophagosomal 
or the endolysosomal pathways. In recent years, researchers 
have also started to provide insights into the physiological 
roles of connexin ubiquitination in specific tissue types and 
how dysregulation of this process may contribute to loss of 
gap junctions during disease pathogenesis. This review pro-
vides an up-to-date overview of the current understanding 
of the role of connexin ubiquitination in the regulation of 
gap junctional intercellular communication. We also discuss 
the emerging physiological and pathophysiological implica-
tions of connexin ubiquitination, focusing on the heart, lens 
and central nervous system. The implications of connexin 
ubiquitination for cancer pathogenesis have previously been 
reviewed elsewhere [33] and this topic will, therefore, not 
be covered here.
Connexin biosynthesis and assembly 
into gap junctions
Connexin proteins are named according to their approxi-
mate molecular weight (in kDa) [1]. The best studied and 
among the most ubiquitously expressed connexin isoforms 
in human tissues is connexin 43 (Cx43) [1]. The connex-
ins are four-pass transmembrane proteins displaying their 
N- and C-terminal tails in the cytosol (Fig. 1a) [34]. The 
transmembrane domains and the two extracellular loops are 
highly conserved between the connexin family members. 
In contrast, the intracellular loop and N- and C-terminal 
tails exhibit great variation in their length and amino acid 
sequence between connexins. These regions have important 
roles in modulating gap junction channel gating and intra-
cellular trafficking of connexins. For instance, the C-termi-
nal tail of Cx43 contains multiple sites for protein–protein 
Fig. 1  Connexins, connexons and gap junction channels. a Connex-
ins have four transmembrane domains, which are connected by two 
extracellular loops and one intracellular loop. The N- and C-termini 
are both located in the cytosol. b Connexins form hexamers called 
connexons. Connexins can combine with either the same or different 
connexin isoforms, forming homomeric or heteromeric connexons, 
respectively. c Connexons form gap junction channels by interacting 
with either identical homomeric or heteromeric connexons in adja-
cent cells, forming homotypic channels, or with different homomeric 
or heteromeric connexons, forming heterotypic channels
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interactions and post-translational modifications that play 
important roles in the regulation of gap junctions [10, 35].
Connexins are co-translationally inserted into the endo-
plasmic reticulum [36, 37]. A subpool of newly synthe-
sized connexins undergoes endoplasmic reticulum-asso-
ciated degradation (ERAD), a process in which they are 
retrotranslocated into the cytosol and degraded by the pro-
teasome (Fig. 2) [38–40]. Connexins that are spared from 
ERAD are transported from the endoplasmic reticulum 
via the Golgi apparatus and the trans-Golgi network to the 
plasma membrane [41, 42]. Along the secretory pathway 
from the endoplasmic reticulum to the plasma membrane, 
connexins oligomerize into hexameric structures called 
connexons [43–45]. Connexons can consist of either six 
similar connexin isoforms or a combination of different 
connexin isoforms, referred to as homomeric and hetero-
meric connexons, respectively (Fig. 1b) [46, 47].
Fig. 2  Intracellular trafficking and ubiquitination and SUMOyla-
tion of connexins. Connexins are co-translationally inserted into the 
endoplasmic reticulum and transported through the Golgi, through 
the trans-Golgi and to the plasma membrane. Along their traffick-
ing to the plasma membrane, connexins oligomerize into connexons. 
A subpool of the newly synthesized connexins undergoes ERAD, in 
which connexins are retrotranslocated to the cytosol and degraded 
by proteasomes. In the plasma membrane, connexons can function 
as hemichannels or diffuse to the periphery of gap junctions, where 
they can dock with connexons in adjacent cells to form intercellular 
channels. During endocytosis of gap junctions, both membranes of 
the junctions are internalized into one of the cells, thereby forming 
a connexosome, also called an annular gap junction. Three different 
pathways for trafficking of connexins to lysosomes are illustrated in 
the figure: (1) direct fusion between connexosomes and lysosomes, 
(2) sequestration of the connexosome by a phagophore and subse-
quent fusion between an autophagosome containing the connexo-
some and a lysosome, and (3) transformation of the connexosome 
into a connexin-enriched, multivesicular endosome with a single 
limiting membrane, which is associated with the fusion between the 
connexosome and early endosomes. Connexins are then sorted from 
early endosomes via late endosomes to lysosomes. Connexons at the 
plasma membrane that are not assembled into gap junctions can also 
undergo endocytosis, but their intracellular trafficking is poorly char-
acterized. They are possibly transported to early endosomes (indi-
cated by a question mark). Following endocytosis, connexins may 
undergo recycling to the plasma membrane, possibly from the early 
endosomes (indicated by a question mark). Connexin ubiquitination 
has been suggested to be involved in ERAD of certain connexin iso-
forms, gap junction endocytosis, autophagy-mediated degradation 
of connexins and sorting of connexins from early endosomes to lys-
osomes. Eps15 has been suggested to bind to ubiquitinated Cx43 at 
the plasma membrane and to control gap junction endocytosis and 
autophagy-mediated degradation. Tsg101 is part of ESCRT and has 
been suggested to bind to ubiquitinated Cx43 at the limiting mem-
brane of early endosomes and to regulate its sorting into the lumen of 
the endosome. p62 has been suggested to bind to ubiquitinated Cx43 
after gap junction endocytosis and to be involved in the sequestration 
of connexosomes by autophagosomes. Cx43 has also been shown to 
be modified by SUMOylation, which has been suggested to stabilize 
Cx43 and consequently cause increased gap junction size
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In the trans-Golgi network, connexons are packaged 
into vesicles that are transported along microtubules to 
the plasma membrane [18, 21, 22, 48]. Connexons can 
be delivered to regions of un-apposed plasma membrane 
where they diffuse laterally in the lipid bilayer until they 
reach the periphery of existing gap junctions [18, 21, 49, 
50]. Alternatively, connexons can be sorted directly to, or in 
the immediate vicinity of, existing gap junctions [22]. The 
connexons then dock with connexons in the plasma mem-
brane of neighboring cells to form gap junction intercel-
lular channels. Connexons can form channels either with 
identical homomeric or heteromeric connexons in adjacent 
cells (homotypic channels) or with channels with different 
homomeric or heteromeric connexons (heterotypic chan-
nels) (Fig. 1c) [46, 47]. The connexin composition of the 
gap junction channels strongly affects the conductance and 
selectivity of the channels.
In addition to full-length Cx43, six N-terminally trun-
cated Cx43 isoforms can form as a result of internal trans-
lation initiation [51–54]. Emerging evidence indicates that 
such truncated versions of Cx43 have important roles in con-
trolling the intracellular trafficking of full-length Cx43 [41, 
42]. For instance, a truncated 20-kDa Cx43 isoform, termed 
GJA1-20 k, has been shown to increase the delivery of Cx43 
hemichannels to cardiac intercalated discs to increase the 
gap junction plaque size [55]. In addition, truncated Cx43 
isoforms may have important functions in the nucleus. In 
accordance with this notion, GJA1-20 k was recently dem-
onstrated to control neural crest cell migration in vivo by 
directly regulating N-cadherin transcription [56].
Endocytosis and degradation of gap 
junctions
During gap junction endocytosis, both membranes of the 
junction are internalized into one of the adjacent cells, 
thereby forming a double-membrane vesicle called an 
annular gap junction or connexosome [57, 58]. Either an 
entire gap junction or only a fragment of it can be inter-
nalized. The endocytosis of gap junctions involves clathrin 
[59–62]. Cx43 contains two functional tyrosine-based motifs 
(265YAYF268 and 286YKLV289) in its C-terminal tail that con-
form to the consensus YXXϕ (where Y is tyrosine, X is 
any amino acid and ϕ is an amino acid with a bulky hydro-
phobic side chain) [63, 64]. These motifs bind to the clath-
rin adaptor AP-2, which then recruits clathrin directly or 
indirectly via the clathrin adaptor Dab2 [63]. Other proteins 
shown to be involved in gap junction endocytosis include 
dynamin, 14-3-3 and the retrograde actin motor myosin-VI 
[62, 65–67].
Subsequent to gap junction endocytosis, connexins can 
follow different post-endocytic pathways before they are 
degraded in lysosomes (Fig. 2) [68–70]. Sometimes, con-
nexosomes can fuse directly with lysosomes [30, 71–73]. 
In other situations, they can be sequestered by autophago-
somes, which subsequently fuse with lysosomes [74–78]. 
Moreover, connexosomes have been suggested to be able to 
undergo a transformation into a connexin-enriched multive-
sicular endosome, which is associated with their fusion with 
early endosomes [79–82]. Some studies also indicate that 
following endocytosis, connexins can under certain condi-
tions undergo recycling from endocytic compartments back 
to the plasma membrane [32, 75, 81, 83–85]. It has also been 
suggested that Cx43 can be transported directly from early 
secretory compartments to lysosomes without prior transport 
to the plasma membrane [30].
Post‑translational modifications 
of connexins
Connexins are subjected to several different types of post-
translational modifications, which contribute to the regula-
tion of gap junctions by different mechanisms [86]. Among 
the post-translational modifications of connexins that 
have been identified are phosphorylation, ubiquitination, 
SUMOylation, acetylation, methylation, hydroxylation and 
nitrosylation [86].
Kinases known to catalyze the phosphorylation of Cx43 
include mitogen-activated protein kinase (MAPK), protein 
kinase C (PKC), casein kinase 1, protein kinase A, c-Src and 
v-Src [87]. Phosphorylation regulates several stages of the 
connexin “life cycle”. For instance, phosphorylation of Cx43 
on serine or tyrosine residues located in the C-terminal tail 
has been shown to regulate Cx43 trafficking from the Golgi 
apparatus to the plasma membrane, the oligomerization of 
Cx43 into connexons, the assembly of connexons into gap 
junctions, the gating of gap junction channels, and gap junc-
tion endocytosis and degradation [88]. As described below, 
increasing evidence suggests that gap junction endocytosis 
and connexin degradation are controlled by complex cross-
talk between connexin phosphorylation and ubiquitination.
The ubiquitin system
Ubiquitin is a small globular protein that can be covalently 
attached to the ε-amino group of an internal lysine residue or 
free N-terminal α-amino group of the substrate, in a process 
known as ubiquitination [89]. A substrate can be subjected to 
different types of ubiquitin modifications, each of which can 
have different effects on the substrate. Proteins can be modified 
by a single ubiquitin, in a process known as monoubiquitina-
tion; by single ubiquitin moieties on several lysines, known 
as multiple monoubiquitination; or by a polyubiquitin chain, 
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known as polyubiquitination. Ubiquitin has seven lysine resi-
dues that can all be involved in polyubiquitination, forming 
linear or branched ubiquitin chains. The distinct ubiquitin 
modifications are recognized by different effector proteins with 
specific ubiquitin-binding domains, thereby coupling the ubiq-
uitination of a substrate to a downstream event, such as protein 
degradation, sorting to a specific subcellular location or assem-
bly of a signaling complex [89]. For instance, modification 
of transmembrane proteins by polyubiquitin chains linked via 
Lys63 may act as a signal for their regulated endocytosis and 
subsequent targeting to lysosomes [89]. In contrast, modifica-
tion of proteins by polyubiquitin chains linked via Lys48 may 
target proteins for degradation by the 26S proteasome [89].
Conjugation of ubiquitin to the target protein proceeds 
through a cascade mechanism that involves three enzymes: 
E1 ubiquitin-activating enzyme, E2 ubiquitin-conjugating 
enzyme and E3 ubiquitin ligase [90]. First, ubiquitin forms 
a high-energy thioester bond with a cysteine residue of an 
E1 ubiquitin-activating enzyme, a process requiring ATP. 
Ubiquitin is then transferred to an E2 ubiquitin-conjugating 
enzyme, forming a similar thioester linkage with a specific 
catalytic cysteine residue. E3 ubiquitin ligases recruit E2 
ubiquitin-conjugating enzymes loaded with ubiquitin. The 
E3 ubiquitin ligase then recognizes a specific substrate and 
facilitates or directly transfers and conjugates ubiquitin to 
the target protein. E3 ubiquitin ligases can either conjugate 
ubiquitin to lysine residues in the target protein or conjugate 
ubiquitin to already attached ubiquitins, forming polyubiq-
uitin chains [90].
The key regulatory determinants in protein degrada-
tion are the E3 ubiquitin ligases. While the human genome 
encodes two E1 activating enzymes and 37 E2 conjugating 
enzymes, it encodes over 600 E3 ubiquitin ligases [90]. E3 
ubiquitin ligases are generally grouped into three subfami-
lies: the really interesting new gene (RING) type E3s, the 
U-box E3s and the homologous to E6-AP carboxyl terminus 
(HECT) domain-containing E3s [90].
Deubiquitinating enzymes are proteases that cleave ubiq-
uitin off the substrate protein or within ubiquitin moieties 
in a polyubiquitin chain [91]. The human genome encodes 
approximately 100 deubiquitinating enzymes, the majority 
of which are cysteine proteases. The E3 ubiquitin ligases and 
deubiquitinating enzymes are key regulators of numerous 
intracellular processes and have been linked to the patho-
genesis of a number of human diseases, including cancer 
and neurodegenerative disorders [92].
Connexin ubiquitination
The first experimental evidence to indicate that Cx43 
is ubiquitinated was provided by Laing and Beyer [27]. 
Using E36 Chinese hamster ovary cells containing a 
temperature-sensitive defect in the ubiquitin-activating pro-
tein E1, the authors also demonstrated that efficient Cx43 
degradation requires an intact ubiquitin conjugation system 
[27]. In accordance with the notion that ubiquitination is 
involved in the regulation of gap junctions, Rütz and Hül-
ser demonstrated by electron microscopy that ubiquitin is 
present in gap junction plaques, as determined by immuno-
gold labeling of freeze-fractured plasma membranes [93]. 
Subsequent studies carried out in our laboratory indicated 
that endocytosis of gap junctions and Cx43 degradation 
may be regulated by crosstalk between Cx43 phosphoryla-
tion and ubiquitination. Using as a model system IAR20 
rat liver epithelial cells, which express Cx43 endogenously, 
we found Cx43 ubiquitination to be induced by epidermal 
growth factor (EGF) [28]. The EGF-induced ubiquitination 
of Cx43 was MAPK dependent and was associated with 
increased endocytosis and degradation of gap junctions. 
Subsequently, treatment of cells with the tumor promoter 
12-O-tetradecanoylphorbol-13-acetate (TPA), a potent acti-
vator of PKC, was found to result in strongly increased Cx43 
ubiquitination, which correlated with enhanced gap junction 
endocytosis and degradation of Cx43 in lysosomes [94]. As 
determined by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis, Cx43 in IAR20 cells appeared to be modi-
fied by one to four ubiquitin moieties [28, 94]. Analyses of 
the solubility of the ubiquitinated Cx43 pool in the detergent 
Triton X-100 indicated that Cx43 can be ubiquitinated while 
assembled into gap junctions and that Cx43 can remain ubiq-
uitinated during gap junction endocytosis and along its sort-
ing to early endosomes [81, 95].
Studies by Cuervo and colleagues have demonstrated that 
ubiquitination of Cx43 is induced in response to activation 
of macroautophagy by serum starvation [74]. Cx43 ubiq-
uitination acts as a signal for gap junction endocytosis and 
autophagy-mediated degradation by recruiting the ubiquitin-
binding protein Eps15 (epidermal growth factor receptor 
substrate 15) [74, 96] (Fig. 2). It has been suggested that 
Eps15 acts as an intermediate bridge molecule between ubiq-
uitinated Cx43 and the autophagy machinery at the plasma 
membrane [74, 96]. Cx43 has also been shown to bind to 
the ubiquitin-binding autophagic adaptor p62 (also known 
as SQSTM1) [74, 76, 78]. The interaction between Cx43 
and p62 increases in response to serum starvation or when 
a ubiquitin molecule is fused in-frame to the C-terminus of 
Cx43 to mimic Cx43 ubiquitination [74]. Cx43 co-localizes 
with p62 in intracellular vesicular compartments [74, 76, 
78]. Moreover, depletion of p62 has been shown to result 
in accumulation of connexosomes [76]. These observations 
raise the possibility that ubiquitination of Cx43 may have 
a role in the sequestration of connexosomes by autophago-
somes by recruiting p62 [74, 76, 78].
Cx43 ubiquitination has also been proposed to control its 
post-endocytic sorting from early endosomes to lysosomes 
 M. Z. Totland et al.
1 3
[81]. Ubiquitinated forms of Cx43 have been suggested to 
be recognized by ubiquitin-binding proteins of the endoso-
mal sorting complex required for transport (ESCRT), which 
is located at the limiting membrane of endosomes (Fig. 2). 
ESCRT is then thought to mediate the deubiquitination and 
subsequent sorting of Cx43 into the lumen of the endosomes 
[81]. In accordance with this notion, Cx43 has been shown 
to interact with the ubiquitin-binding protein Tsg101 (tumor 
susceptibility gene 101 protein), a member of ESCRT [97]. 
Depletion of Tsg101 results in increased Cx43 protein lev-
els and enhanced levels of functional gap junctions at the 
plasma membrane, possibly due to increased recycling of 
Cx43 from early endosomes to the plasma membrane [81]. 
Moreover, under conditions in which Tsg101 is co-depleted 
with another ubiquitin-binding protein and member of 
ESCRT, Hrs (hepatocyte growth factor-regulated tyrosine 
kinase substrate), Cx43 accumulates at the limiting mem-
brane of early endosomes in a hyperubiquitinated form [81].
In addition to Cx43, several other connexin isoforms have 
been shown to be ubiquitinated (Table 1). As well as playing 
a role in modulating gap junction endocytosis and post-endo-
cytic sorting of connexins to lysosomes, connexin ubiquit-
ination has been shown to be involved in ERAD. However, 
the involvement of ubiquitination in ERAD appears to be 
connexin isoform specific. For instance, ERAD of Cx43 
occurs independently of ubiquitination, whereas ERAD of 
Cx32 and Cx40 involves polyubiquitination [98–100]. Kelly 
et al. have shown that ERAD of connexins is inhibited by 
mild forms of cytosolic stress at a step before their disloca-
tion into the cytosol [40]. To investigate the mechanisms 
underlying this inhibition of connexin degradation, a mutant 
version of Cx32 associated with Charcot–Marie–Tooth 
X-linked peripheral neuropathy was studied [99]. This 
mutant Cx32 is confined to the endoplasmic reticulum 
and thus not subject to lysosomal degradation, and it was 
found to be modified by polyubiquitination [99]. Moreover, 
its level of polyubiquitination was found to be reduced in 
response to cytosolic stress, which was associated with its 
reduced ERAD [99]. These observations suggest that the 
inhibition of ERAD of connexins induced by cytosolic stress 
may be due to reduced connexin polyubiquitination.
An important question is which lysines in Cx43 and other 
connexin isoforms act as ubiquitination sites, and how ubiq-
uitination of specific lysine residues affects gap junction 
levels. A study by Dunn et al. found that a mutant version 
of Cx43 with all lysines converted to arginines behaves simi-
larly to Cx43-wt in the presence of proteasomal and lysosomal 
inhibitors [101]. The authors also demonstrated that protea-
somal inhibition causes increased activation of Akt (protein 
kinase B), which is associated with enhanced Akt-mediated 
phosphorylation of Cx43 and, consequently, stabilization of 
Cx43 gap junctions [101]. The authors concluded that ubiq-
uitination and proteasomal degradation of Akt, but not Cx43 
ubiquitination, is involved in the regulation of Cx43 turnover. 
A subsequent study by Kells-Andrews, Margraf et al. indicated 
that two lysine residues located in the C-terminal tail of Cx43, 
Lys264 and Lys303 act as ubiquitin conjugation sites [102]. 
Mutation of these lysine residues to arginines resulted in the 
accumulation of Cx43 at the plasma membrane and increased 
its half-life. Under these conditions, Cx43 was found to be 
in a hyper-phosphorylated state, which could indicate that 
Cx43 ubiquitination is triggered by Cx43 phosphorylation 
under basal conditions. On the basis of these observations, 
the authors concluded that Cx43 ubiquitination is required 
for the constitutive gap junction internalization and degrada-
tion [102]. A recent study by Alaei et al. demonstrated that 
mutating five lysine residues in the C-terminal tail of Cx32 to 
arginines resulted in both reduced Cx32 acetylation and ubiq-
uitination, and both these modifications were suggested to be 
involved in regulating Cx32 turnover [103]. Acetylation and 
ubiquitination were suggested to result in Cx32 stabilization 
and degradation, respectively [103]. The authors also demon-
strated that mutating the five above-mentioned lysine residues 
to glutamine, which mimics acetylation, results in a stronger 
reduction in Cx32 ubiquitination as compared with when they 
are mutated to arginines [103]. These observations raise the 
possibility that Cx32 ubiquitination is negatively regulated by 
Cx32 acetylation, possibly through direct competition for the 
same lysine residues.
The available experimental evidence indicates that con-
nexins can be subjected to different types of ubiquitin con-
jugation, including monoubiquitination (e.g., [104, 105]), 
multiple monoubiquitination (e.g., [94, 96]) and Lys63- 
or Lys48-linked polyubiquitination (e.g., [98–100, 102, 
106–109]). It is likely that the type of ubiquitination that 
connexins are subjected to varies according to their subcel-
lular localization. In future studies, it will be important to 
provide a more detailed understanding of the type of ubiqui-
tin modifications that connexins are subjected to at different 
subcellular localizations and to better understand the func-
tional consequences of the various types of modifications.
In addition to ubiquitination, Cx43 has been found to be 
modified by the ubiquitin-like protein SUMO (small ubiq-
uitin-related modifier) [110]. In contrast to ubiquitination, 
SUMOylation of Cx43 has been proposed to stabilize Cx43 
at the plasma membrane (Figs. 2 and 3; Table 2) [110]. This 
raises the possibility that gap junction endocytosis and deg-
radation are controlled by an interplay between Cx43 ubiq-
uitination and SUMOylation.
Regulation of Cx43 gap junctions by NEDD4
The available data suggest that Cx43 is regulated by sev-
eral E3 ubiquitin ligases (Fig. 3; Table 2). Among these, 
NEDD4 (neural precursor cell expressed developmentally 
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down-regulated protein 4) is the best characterized. NEDD4 
was originally discovered as a developmentally down-reg-
ulated gene in mouse brain [111]. NEDD4 is the founding 
member of the NEDD4 family of E3 ubiquitin ligases, which 
consists of nine members in humans [112]. The members of 
this protein family are characterized by a C-terminal cata-
lytic HECT domain, a central protein–protein interaction 
region composed of 2–4 WW domains and an N-terminal 
membrane-targeting C2 domain. WW domains are protein 
modules that mediate protein–protein interactions by rec-
ognizing and binding proline-rich motifs and phosphoryl-
ated serine/threonine–proline sites in substrate proteins 
[113]. They are found in a variety of structural and signaling 
proteins and are involved in numerous cellular processes, 
Table 1  Overview of connexin isoforms reported to undergo ubiquitination
eCFP enhanced cyan fluorescence protein, CHO Chinese hamster ovary, eGFP enhanced green fluorescent protein, ERAD endoplasmic reticu-
lum-associated degradation, MDCK Madin–Darby Canine kidney, N2A neuro2A
Connexin Proposed role of ubiquitination Cellular model system References
Cx26 Proteasomal degradation of Cx26 HEK293T human embryo kidney cells exogenously 
expressing FLAG-Cx26 and HA-ubiquitin
[108]
Cx32 ERAD of Cx32 HeLa cervical cancer cells exogenously expressing 
Cx32-HKKSL
[100]
ERAD of Cx32 CHO cells exogenously expressing Cx32-E208K and 
HA-ubiquitin
[99]
Cx32 degradation N2A murine neuroblastoma cells exogenously express-
ing Cx32-Myc
[103]
Cx36 Gap junction endocytosis and lysosomal degradation of 
Cx36
N2A exogenously expressing Cx36-eCFP and HA-
ubiquitin
[125]
Cx40 ERAD of Cx40 HeLa cells exogenously expressing Cx40-wt or Cx40-
G38D
[98]
Cx43 Proteasomal degradation of Cx43 E36 CHO cells [27]
Gap junction endocytosis and sorting of Cx43 from early 
endosomes to lysosomes
IAR20 rat liver epithelial cells [28, 79, 81, 94]
Gap junction endocytosis HeLa cells exogenously expressing Cx43 [96]
Gap junction endocytosis and autophagy-mediated 
degradation of Cx43
COS-7 monkey kidney fibroblasts exogenously express-
ing Cx43
[74, 162]
Gap junction endocytosis and Cx43 degradation C6 rat glioma cells exogenously expressing Cx43 [104]
Gap junction endocytosis and Cx43 degradation MDCK canine kidney cells exogenously expressing 
Cx43
[102]
Gap junction endocytosis and sorting of Cx43 from early 
to late endosomes
HeLa cells exogenously expressing Cx43 [105]
Proteasomal or lysosomal degradation of Cx43 MCF7 and BT474 breast cancer cells [163]
Autophagy-mediated degradation of Cx43 HEK293T cells exogenously expressing HA-Cx43 [107]
Lysosomal degradation of Cx43 HEK293T cells exogenously expressing Cx43 [124]
Gap junction endocytosis Rat primary neonatal ventricular cardiomyocytes [132]
Gap junction endocytosis and lysosomal degradation of 
Cx43
Rat primary neonatal ventricular cardiomyocytes [164]
Remodeling of gap junctions during cardiac ischemia HL-1 atrial cardiomyocyte cells [133]
Remodeling of gap junctions during cardiac ischemia Rat heart Langendorff perfusion model (in vivo Cx43 
ubiquitination)
[106]
Gap junction endocytosis HaCaT human keratinocytes exogenously expressing 
Cx43-wt or Cx43-S373A
[67]
Lysosomal degradation of Cx43 Cultured neonatal rat ventricular cardiomyocytes [138]
Proteasomal degradation of Cx43 NN1003A rabbit lens epithelial cells [146]
Proteasomal degradation of Cx43 Lens (in vivo Cx43 ubiquitination) [147]
Proteasomal degradation of Cx43 Human lens epithelial cells [147]
Proteasomal degradation of Cx43 Neonatal rat spinal cord astrocytes [165]
Proteasomal degradation of Cx43 Primary rat astrocytes [166]
Cx45.6 Proteasomal degradation of Cx45.6 N2A cells exogenously expressing eGFP-Cx45.6 and 
ubiquitin-Myc
[109]
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including protein trafficking. WW domains consist of 38–40 
amino acids and are characterized by two highly conserved 
tryptophan residues separated by 20–23 amino acids [113]. 
Based on their binding motif preference, WW domains are 
divided into five classes [113]. The WW domains of NEDD4 
belong to class I, which bind to PY motifs (PPXY, where 
P is proline, X is any amino acid, and Y is tyrosine) in the 
substrate proteins. Cx43 contains a PY motif in its C-termi-
nal tail (283PPGY286) [64].
In 2006, Leykauf et al. identified NEDD4 as the first E3 
ubiquitin ligase to interact with Cx43. As determined by 
pull-down assays, rat NEDD4 (rNEDD4) was found to bind 
to the C-terminal tail of rat Cx43 (rCx43) and the interac-
tion was shown to involve all three WW domains (WW1–3) 
Fig. 3  Overview of proteins involved in controlling gap junctions by 
connexin ubiquitination or SUMOylation. The figure depicts the pro-
teins identified to date that participate in the regulation of gap junc-
tion intercellular communication through connexin ubiquitination or 
SUMOylation and the possible subcellular localizations where they 
may interact with connexins. For details, see Table  2 and the main 
text
Table 2  Overview of proteins 
reported to be involved in 
controlling gap junctions 
through connexin ubiquitination 
or SUMOylation
SENP1/2 SUMO/sentrin-specific peptidase, UBC9 SUMO-conjugating enzyme UBC9
Protein type Protein name Connexin iso-
form
References
E3 ubiquitin ligase NEDD4 Cx43 [74, 96, 105, 114, 115]
SMURF2 Cx43 [79, 84]
WWP1 Cx43 [124]
TRIM21 Cx43 [104]
LNX1 and -2 Cx36 [125]
Deubiquitinating enzyme AMSH Cx43 [126]
USP8 Cx43 [107]
SUMO E2 conjugating enzyme UBC9 Cx43 [110]
DeSUMOylating enzyme SENP1/2 Cx43 [110]
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of rNEDD4 [114]. Only WW2 was suggested to bind to the 
PY motif of Cx43, whereas the WW1 and WW3 domains 
were suggested to interact with other regions in the Cx43 
C-terminal tail [114]. More recently, however, using vari-
ous biophysical techniques, including nuclear magnetic reso-
nance spectroscopy, Spagnol et al. provided evidence that 
all three WW domains of rNEDD4 bind to the PY motif of 
rCx43 [115]. WW2 was shown to have the highest binding 
affinity for the PY motif of rCx43, followed by WW3 and 
WW1. Mutation of the tyrosine in the PY motif (Y286A) 
led to a significant reduction in binding affinity for all WW 
domains, underscoring the importance of this residue in the 
interaction between the C-terminal tail of Cx43 and NEDD4.
Both the two aforementioned studies further indicated 
that phosphorylation of Cx43 is important for the interac-
tion with NEDD4. Leykauf et al. found that treating cells 
with EGF, which causes MAPK-mediated phosphorylation 
of Cx43 at serine residues 255, 262, 279 and 282, increased 
the binding capacity of the WW3 domain of NEDD4 to 
Cx43 [114]. Interestingly, Ser279 and Ser282 are located 
just N-terminally to the PY motif, and phosphorylation 
of these residues (279pSPMpSPPGY286 where pS is phos-
phoserine) creates a potential class IV WW domain-binding 
motif [(pS/pT)P] adjacent to the PY motif [113]. Using pep-
tides containing the PPXY motif, as well as the potential 
class IV motif, Spagnol et al. showed that phosphorylation 
of Ser282 significantly increased the affinity of all three WW 
domains of NEDD4 [115]. The binding affinity of WW2 
was further increased when both Ser279 and Ser282 were 
phosphorylated, while phosphorylation of Ser279 alone 
had no influence. The contacts formed by phosphorylation 
of Ser279 and Ser282 were found to cause the region of 
the C-terminal tail of Cx43 encompassing the PY motif to 
form a horseshoe-shaped arrangement that fits into a groove 
formed by the NEDD4 WW2 domain. Taken together, these 
data raise the possibility that MAPK-mediated phosphoryla-
tion of the C-terminal tail of Cx43 increases the binding to 
NEDD4 in vivo, providing a possible mechanism for how 
the crosstalk between phosphorylation and ubiquitination of 
Cx43 is mediated.
The fact that the members of the NEDD4 family harbor 
multiple WW domains raises the possibility that tandem 
WW domain repeats may cooperate to enhance specificity 
and binding affinity [116]. For instance, the binding of the 
NEDD4 family member NEDD4-2 to its target SMAD2/3 
first involves the phosphorylation-dependent binding of its 
WW3 domain to a site downstream of a PY motif, which 
positions the WW2 domain so that it can bind the PY motif, 
ultimately enhancing the total binding affinity [117]. The 
WW2 and WW3 domains of rNEDD4 have close proximity, 
raising the possibility that they could bind to the C-terminal 
tail of Cx43 in a cooperative manner. However, Spagnol 
et al. did not observe any cooperative binding of these two 
WW domains to a peptide containing the (pS/pT)P and 
PPXY motifs of Cx43, suggesting that they bind to Cx43 
individually [115].
In accordance with the notion that NEDD4 binds to Cx43 
via the PY motif, mutation of the first proline in this motif 
to a leucine (P283L) has been shown to result in reduced 
binding of NEDD4 to Cx43 as determined by co-immuno-
precipitation [96], reduced Cx43 ubiquitination [96] and 
increased Cx43 protein levels [64]. Moreover, ectopic over-
expression of NEDD4 in HeLa cells stably transfected with 
Cx43 or in C33A cervical carcinoma cells, which express 
Cx43 endogenously, has been shown to promote Cx43 ubiq-
uitination and endocytosis, which is associated with a nearly 
complete loss of gap junctions [105]. The NEDD4-induced 
Cx43 endocytosis was found to be accompanied with loss 
of Cx43 protein levels due to its increased degradation via 
the endolysosomal pathway [105]. NEDD4 that contains an 
inactivating mutation in the catalytic cysteine of the HECT 
domain did not affect the Cx43 ubiquitination status, gap 
junction levels or the Cx43 protein level [105]. Thus, the 
ability of NEDD4 to promote ubiquitination, endocytosis 
and lysosomal degradation of Cx43 requires a functional 
HECT domain. NEDD4 is also involved in mediating the 
endolysosomal degradation of Cx43 in response to PKC acti-
vation [105]. In addition, NEDD4-induced ubiquitination of 
Cx43 has been suggested to act as a signal for gap junction 
endocytosis and autophagy-mediated degradation through 
recruitment of Eps15 [74, 96].
Other E3 ubiquitin ligases involved 
in regulating Cx43 gap junctions
SMURF2
SMURF1 and -2 (SMAD ubiquitination regulatory factor-1 
and -2) are members of the NEDD4 family and were originally 
identified as important regulators of the transforming growth 
factor-β (TGF-β)/bone morphogenic protein signaling pathway 
by catalyzing the ubiquitination and degradation of SMAD 
proteins and the TGF-β receptor [118, 119]. Subsequent stud-
ies identified several other substrate proteins of SMURF1 and 
-2, and they were shown to play central roles in processes such 
as cell proliferation, differentiation, migration and senescence 
[120]. SMURF2 has been found to bind to Cx43, as deter-
mined by co-immunoprecipitation, and depletion of SMURF2 
results in enhanced Cx43 levels and enlarged gap junctions, 
which is associated with increased gap junction intercellu-
lar communication [79]. SMURF2 also mediates the PKC-
induced endocytosis and degradation of Cx43 [79]. In IAR20 
cells, but not in HeLa cells, SMURF2 is also required for the 
remodeling of Cx43 gap junctions during mitosis [84]. How-
ever, it is unclear whether SMURF2 regulates gap junction 
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endocytosis directly by catalyzing Cx43 ubiquitination or indi-
rectly via another, yet unknown, protein [79].
TRIM21
TRIM21 (cytosolic Fc receptor tripartite motif 21) is a 
member of the tripartite motif-containing (TRIM) pro-
tein family of RING E3 ubiquitin ligases [121]. TRIM21 
links Fc-mediated antibody recognition to the ubiquitin pro-
teasome system and has also been linked to the initiation 
of autophagy [121]. In addition, TRIM21 has been shown 
to regulate cell proliferation and cell death, and among its 
known substrate proteins is the cyclin-dependent kinase 
inhibitor p27 [122, 123]. Chen and colleagues have demon-
strated that Cx43 interacts with TRIM21, as determined by 
both liquid chromatography tandem mass spectrometry and 
co-immunoprecipitation [104]. Through confocal micros-
copy, TRIM21 was found to co-localize with Cx43 at gap 
junctions. Analysis of TRIM21-mediated Cx43 ubiquitina-
tion in vitro with cell lysates of C6 rat glioma cells that exog-
enously expressed Cx43 (C6-Cx43) or astrocytes showed 
that mono- and diubiquitinated forms of Cx43 accumulated 
approximately 30 min after the initiation of the procedure. 
After 3 h, most Cx43 was modified by polyubiquitination 
and/or multiple monoubiquitination. Analysis of TRIM21/
Cx43 complexes by high-performance size exclusion chro-
matography showed that complexes that consisted of highly 
phosphorylated Cx43 also contained ubiquitinated Cx43. 
Moreover, inhibition of the trafficking of Cx43 from the 
endoplasmic reticulum to the Golgi apparatus with Brefeldin 
A resulted in the near complete loss of both phosphorylated 
and ubiquitinated forms of Cx43. Mathematical modeling 
demonstrated that EGF-induced phosphorylation of Cx43 
was associated with increased Cx43 ubiquitination. Col-
lectively, these observations support the notion that Cx43 
degradation is controlled by crosstalk between Cx43 phos-
phorylation and ubiquitination.
In addition to the above-mentioned E3 ubiquitin ligases, 
another member of the NEDD4 family, WWP1, has been 
shown to regulate Cx43 gap junctions in cardiomyocytes 
[124] and the E3 ubiquitin ligases LNX1 and -2 (ligand 
of NUMB Protein-X1 and -2) were recently found to have 
important roles in controlling the level of Cx36 gap junc-
tions in the central nervous system [125], as is further dis-
cussed below.
Regulation of Cx43 gap junctions 
by deubiquitinating enzymes
Cx43 ubiquitination is a reversible process, and two deu-
biquitinating enzymes, AMSH [associated molecule with 
the SH3 domain of STAM (signal transducing adaptor 
molecule)] and USP8 (ubiquitin carboxyl-terminal hydrolase 
8) have been found to regulate Cx43 deubiquitination and 
lysosomal degradation (Fig. 3; Table 2) [107, 126].
AMSH
AMSH has been shown to bind to Cx43, as determined by 
co-immunoprecipitation, and to partly co-localize with Cx43 
at the plasma membrane and in intracellular compartments 
[126]. Ectopic overexpression of a catalytically inactive ver-
sion of AMSH results in strongly increased levels of Cx43 
modified by K63-linked polyubiquitin chains, which is asso-
ciated with an increased Cx43 degradation rate. Upon over-
expression of the catalytically inactive version of AMSH, 
Cx43 is observed on the limiting membrane of vesicular 
structures of the endolysosomal system, whereas the level 
of Cx43 at the plasma membrane is decreased [126]. A simi-
lar loss of Cx43 at the plasma membrane and an increase 
in Cx43 degradation are observed in response to AMSH 
depletion [126]. Accordingly, on overexpression of wild-
type AMSH, the level of Cx43 at the plasma membrane is 
increased. Collectively, these data indicate that AMSH-
mediated deubiquitination of Cx43 counteracts its endo-
cytosis and lysosomal degradation, causing increased gap 
junction levels.
USP8
USP8 was recently shown to bind to the C-terminal tail of 
Cx43, as determined by co-immunoprecipitation [107]. 
Ectopic overexpression of USP8 was found to promote the 
loss of both Cx43 monoubiquitination and polyubiquitin 
chains linked via Lys48 or Lys63, which was associated 
with increased Cx43 protein levels. In accordance with this 
finding, depletion of endogenous USP8 was associated with 
increased Cx43 ubiquitination and reduced Cx43 protein lev-
els due to increased degradation via the autophagosomal 





Given the diverse physiological roles of gap junctions across 
different tissue types, connexin ubiquitination is expected to 
have a wide variety of important physiological implications. 
Below, we highlight recent studies that have started to eluci-
date the role of connexin ubiquitination in the regulation of 
gap junctions in the heart, the lens and the central nervous 
system and the implications of these findings for disease 
pathogenesis.
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Role of connexin ubiquitination in the regulation 
of gap junctions in the heart
The normal heart rhythm depends fundamentally on the cou-
pling of cardiac myocytes by gap junctions [127]. The gap 
junctions are located at the intercalated discs, where they 
mediate the intercellular electrical coupling responsible for 
synchronous contraction of the heart [127]. The principal 
connexins expressed in cardiac myocytes are Cx43, Cx40 
and Cx45, of which Cx43 is the most predominant [127]. 
Cx43 in the heart has a high turnover rate, and regulation 
of Cx43 degradation may be an important mechanism for 
modulating gap junctional communication in the heart under 
normal and pathophysiological conditions [128, 129]. Cx43 
is highly remodeled in the diseased heart [127]. During 
ischemia, Cx43 undergoes rapid dephosphorylation, which 
is associated with electrical uncoupling and alteration in the 
distribution of Cx43 to the sides of the myocyte and to intra-
cellular pools [130, 131].
Nielsen and colleagues have shown that Cx43 in neonatal 
ventricular rat cardiomyocytes is subjected to ubiquitina-
tion and binds to NEDD4 [132]. Moreover, stimulation of 
α-adrenergic Gαq-coupled receptors with noreprinephrine 
was found to cause increased Cx43 ubiquitination, which 
was suggested to be associated with increased internalization 
of gap junctions. Studies from Matesic’s group have identi-
fied a role for the E3 ubiquitin ligase WWP1, a member 
of the NEDD4 family, in regulating Cx43 degradation and 
gap junction size in cardiomyocytes. The authors demon-
strated that global- or cardiomyocyte-specific overexpres-
sion of WWP1 in mice results in lethal ventricular arrhyth-
mias around 8 weeks of age because of a reduction in Cx43 
protein levels in the heart muscle [124]. Overexpression of 
WWP1 did not affect the Cx43 mRNA levels, suggesting 
that the WWP1-induced loss of Cx43 occurs at the post-
translational level. In line with this notion, WWP1 was 
found to partly co-localize with Cx43 in small intracellular 
vesicular compartments of cardiomyocytes. Since WWP1 
did not co-localize with Cx43 at the plasma membrane, it 
was suggested that WWP1 may not regulate gap junction 
internalization, but instead promote the degradation of Cx43 
after internalization. Notably, overexpression of WWP1 in 
cardiomyocytes did not affect the protein levels of Cx40 and 
Cx45, suggesting that WWP1 specifically acts on Cx43. Fur-
thermore, WWP1 overexpression had no effects on N-cad-
herin or desmoplakin protein levels, further corroborating 
the specific effect of WWP1 on Cx43. As determined by co-
immunoprecipitation, Cx43 and WWP1 were found to bind 
to each other when exogenously expressed in human embry-
onic kidney 293T cells [124]. The binding was suggested to 
occur via the PY motif of Cx43. In line with the notion that 
WWP1 promotes Cx43 degradation, the Cx43 protein level 
in 293T cells was reduced in response to co-expression of 
WWP1, whereas a catalytically inactive version of WWP1 
did not affect the Cx43 protein level. Moreover, the WWP1-
induced loss of Cx43 protein levels was associated with a 
robust increase in Cx43 ubiquitination, whereas the inactive 
version of WWP1 did not affect the Cx43 ubiquitination 
status [124].
Studies from Girão’s group indicate that Cx43 ubiquit-
ination is involved in the remodeling of gap junctions dur-
ing acute cardiac ischemia. Using the atrial cardiomyocyte 
cell line HL-1 and organotypic heart cultures as model sys-
tems, they found ischemia to be associated with autophagy-
mediated degradation of Cx43 [133]. The ischemia-induced 
degradation of Cx43 was shown to correlate with increased 
Cx43 ubiquitination and binding to Eps15 and p62, and 
depletion of p62 partly counteracted the degradation of 
Cx43 under these conditions. Increased ubiquitination and 
autophagy-mediated degradation of Cx43 in response to 
ischemia were also observed in organotypic heart cultures 
[133]. Moreover, ischemia was associated with enhanced 
Cx43 ubiquitination, as determined by the rat heart Langen-
dorff perfusion model, and under these conditions, Cx43 was 
found to be modified by K63-linked ubiquitin chains [106]. 
Notably, counteracting Cx43 degradation during ischemia 
with chemical inhibitors of autophagy also prevents the loss 
of ischemia-associated gap junction intercellular communi-
cation [133]. This finding raises the possibility that targeting 
autophagy-mediated degradation of Cx43 could represent 
a potential therapeutic approach for preventing the loss of 
functional gap junctions during heart ischemia [133, 134]. 
The increase in Cx43 ubiquitination in response to ischemia 
is accompanied by recruitment of NEDD4 to intercalated 
discs, where it forms a complex with Cx43 [106]. However, 
depletion of NEDD4 does not counteract Cx43 ubiquitina-
tion or degradation induced by ischemia, suggesting that 
another E3 ubiquitin ligase may be involved in this process 
[133].
Shaw and colleagues have provided further insights 
into the crosstalk between Cx43 phosphorylation and 
ubiquitination and its implications for the loss of gap 
junctions during acute ischemia [67]. Exposing Lan-
gendorff-perfused mouse hearts to global ischemia was 
shown to result in phosphorylation of Ser368, in accord-
ance with previous studies suggesting that phosphoryla-
tion of Cx43 at Ser368 is involved in gap junction remod-
eling during ischemia [135–137]. When a Cx43 construct 
in which Ser373 was mutated to alanine (Cx43-S373A) 
was transiently transfected into HaCaT human keratino-
cytes, it was found to have lost phosphorylation of Ser368, 
as well as Ser255, and to display more Cx43 at the plasma 
membrane than Cx43-wt did. Compared with Cx43-wt, 
Cx43-S373A also displayed strongly reduced ubiquit-
ination, both under basal conditions and in response to 
TPA treatment. In accordance with these observations, 
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TPA was found to induce loss of Cx43-wt at the plasma 
membrane because of increased internalization, whereas 
it did not affect the level of Cx43-S373A [67]. Cx43-
S373A also displayed loss of binding to 14-3-3τ, whose 
normal function is to promote Cx43 internalization [67]. 
Collectively, these data indicate that phosphorylation of 
Cx43 at Ser373 promotes both Cx43 ubiquitination and 
binding to 14-3-3τ, and both events may contribute to 
reduced gap junction levels by promoting increased Cx43 
internalization.
Gemel et  al. have shown that some Cx40 mutants 
linked to atrial fibrillation have reduced stability as 
compared to Cx40-wt, when expressed in HeLa cells or 
HL-1 cardiomyocytes [98]. Among the mutants studied, 
Cx40-G38D showed the most dramatic differences from 
Cx40-wt and was, therefore, characterized in further 
detail. Both Cx40-wt and Cx40-G38D were demonstrated 
to be subjected to polyubiquitination and this modifica-
tion was more prominent for the mutant. Moreover, pro-
teasomal inhibition caused strongly increased levels of 
Cx40-G38D, which was associated with restoration of 
functional gap junctions. Collectively, these observa-
tions suggest that mutations in Cx40 may lead to atrial 
fibrillation by causing increased polyubiquitination and 
ERAD of the mutant protein [98]. The findings also raise 
the possibility that restoring the function of certain Cx40 
mutants linked to atrial fibrillation by reducing their pro-
teasomal degradation may have therapeutical implications 
[98].
Recently, Green and colleagues demonstrated that 
Cx43 ubiquitination is involved in modulating gap junc-
tion levels in cardiac cells in response to loss of des-
moplakin, a key component of desmosomes [138]. 
Desmosomes are cadherin-based intercellular adhesive 
junctions that have important roles in maintaining the 
integrity of the myocardium by tethering the intermedi-
ate filament cytoskeleton to sites of cell–cell adhesion 
[139]. Desmoplakin physically links the intermediate 
filament to the desmosomal cadherin complex and also 
regulates various intracellular signaling pathways [139]. 
Mutations in desmoplakin can cause cardiac disease, 
including deadly arrhythmias [139]. In cardiac cells, 
desmosomes are structurally and functionally associated 
with both adherens junctions and gap junctions. Condi-
tional knock-out of desmoplakin in mouse cardiac cells 
results in a significant reduction in Cx43 protein levels 
[140, 141]. Mechanistically, loss of desmoplakin causes 
activation of the ERK1/2-MAPK pathway, which then 
stimulates phosphorylation of Ser279 and Ser282 within 
the C-terminal tail of Cx43 [138]. In neonatal rat ven-
tricular cardiomyocytes, this phosphorylation event was 
found to be associated with increased Cx43 ubiquitination 
and degradation in lysosomes [138].
Role of connexin ubiquitination in the regulation 
of gap junctions in the lens
The lens is an avascular and transparent organ, whose cells 
are coupled by an extensive network of gap junctions that 
facilitates the exchange of ions and metabolites throughout 
the organ [142, 143]. The mature lens is composed of fiber 
cells covered with a single layer of epithelial cells on the 
anterior hemisphere. The lens continues to grow throughout 
life as epithelial cells at the lens equator differentiate into 
fiber cells. As new fiber cells arise, older cells are pushed 
toward the center and become mature lens fibers. The dif-
ferentiation of epithelial cells into fiber cells involves cell 
elongation and loss of nuclei and organelles [142, 143].
The lens expresses three connexin isoforms in mammals: 
Cx43, Cx46 and Cx50 [142, 143]. These connexins display 
differential spatial distributions, which are related to their 
specific functions in different regions of the lens. Cx43 is 
predominantly expressed in epithelial cells, Cx46 is mainly 
expressed in fiber cells and Cx50 is expressed in both epi-
thelial and fiber cells. Studies on mice with targeted deletion 
of the genes encoding Cx46 or Cx50 have demonstrated that 
Cx46 is essential for lens transparency, and Cx50 is impor-
tant for lens growth and transparency [144, 145]. Mutations 
of the genes encoding Cx46 and Cx50 are one of the com-
mon causes of hereditary cataracts in humans [142, 143].
Takemoto and colleagues have demonstrated that Cx43 
and Cx46 are expressed and regulated in a reciprocal man-
ner in lens epithelial cells in a process that involves Cx43 
ubiquitination [146]. Ectopic overexpression of Cx46 in 
NN1003A rabbit lens epithelial cells was found to cause 
reduced Cx43 protein levels due to proteasome-dependent 
degradation, which was associated with an increase in Cx43 
ubiquitination. The level of Cx50 was not altered under these 
conditions, indicating that the effect was specific for Cx43. 
The study further demonstrated that the C-terminal tail of 
Cx46 was essential and sufficient to induce Cx43 degrada-
tion. Although the exact mechanisms involved in the Cx46-
induced degradation of Cx43 remain to be determined, it 
was suggested that it could be due to increased ERAD [146].
Studies by Liu et al. have identified a novel connection 
between the ubiquitin–proteasome system, gap junctions and 
lens clarity [147]. Degradation of proteins by the ubiqui-
tin–proteasome system in the lens was found to be perturbed 
by overexpression of a ubiquitin with a mutation in the 
Lys6 residue (ubiquitin-K6W). Although this mutant form 
of ubiquitin did not affect the ability of ubiquitin to form 
polyubiquitin chains, the ubiquitin conjugates formed under 
these conditions were not recognized by the proteasome 
and were thus resistant to proteasomal degradation [148]. 
Therefore, ubiquitin-K6W acts as a specific upstream domi-
nant negative inhibitor of the ubiquitin–proteasome system. 
Expression of ubiquitin-K6W in lenses in vivo was shown to 
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result in accumulation of ubiquitin conjugates, stabilization 
of numerous regulatory proteins and cell cycle arrest [149, 
150]. It also slowed the differentiation of epithelial cells into 
fibers and the removal of nuclei [151]. Lenses expressing 
ubiquitin-K6W were found to have a significant increase 
in  Ca2+ concentration [147]. The elevated  Ca2+ concentra-
tion resulted in hyperactivation of calpain, one of the domi-
nant proteases in mammalian lenses, and as a consequence 
increased cleavage of calpain substrates, causing develop-
mental defects and cataracts. Interestingly, lenses expressing 
ubiquitin-K6W were found to have significantly higher levels 
of Cx43 protein, whereas the levels of Cx46 and Cx50 were 
decreased. As the mRNA levels for Cx43 were comparable 
in lenses expressing ubiquitin-K6W and ubiquitin-wt, it was 
suggested that the increased level of Cx43 in lenses express-
ing ubiquitin-K6W was due to impaired degradation rather 
than increased synthesis of Cx43. In accordance with this 
notion, lenses expressing ubiquitin-K6W were found to have 
accumulated ubiquitinated Cx43, much of which would be 
expected to have incorporated ubiquitin-K6W and, therefore, 
be resistant to degradation. The study further suggested that 
the increase in  Ca2+ concentration in the lenses expressing 
ubiquitin-K6W was partly due to the increased Cx43 protein 
levels. Corroborating the in vivo data, ectopic expression 
of ubiquitin-K6W in human lens epithelial cells resulted in 
increased levels of ubiquitinated Cx43, which was associated 
with increased protein levels. Together, these observations 
suggest that Cx43 ubiquitination may have important roles 
in modulating  Ca2+ concentration and, as a consequence, 
calpain activity in the lens. The findings also raise the pos-
sibility that exploiting the ubiquitin–proteasome system and 
the  Ca2+-calpain pathway may provide new approaches to 
preventing or curing human cataracts [147].
In addition to Cx43, Cx45.6, the chick ortholog of mam-
malian Cx50, has been found to be modified by polyubiq-
uitin chains when overexpressed in neuro2A (N2A) mouse 
neuroblastoma cells [109]. In accordance with this finding, 
the degradation of Cx45.6 in lens primary cultures was 
shown to be mediated primarily through the proteasomal 
pathway. Minogue et al. have shown that a mutant version of 
Cx50 that has a frameshift after amino acid 255 and causes 
recessive congenital cataracts undergoes strongly enhanced 
ERAD as compared to Cx50-wt when stably expressed in 
HeLa cells [152]. Accordingly, the cellular levels of the 
mutant Cx50 are considerably lower than that of Cx50-wt, 
and it rarely forms gap junctions. In line with the notion 
that the mutant Cx50 is subjected to ERAD, it is able to 
form functional gap junction plaques in response to protea-
somal inhibition, which is associated with an increase in 
gap junction intercellular communication [152]. Moreover, 
the chemical inhibitor eeyarestatin I, which inhibits ERAD 
by targeting p97-associated deubiquitination [153], causes 
a considerably stronger increase in the cellular level of the 
mutant Cx50 than that of Cx50-wt. Under these conditions, 
both the mutant Cx50 and Cx50-wt are detected at higher 
apparent molecular masses in immunoblots, likely due to 
polyubiquitination [152].
Role of connexin ubiquitination in the regulation 
of gap junctions in the central nervous system
Cx36 is, to date, the most abundantly detected connexin 
in neurons in mammals, and it forms the majority of elec-
trical synapses in the mammalian central nervous system 
[154]. Cx36 is expressed in multiple types of neurons in the 
retina, brain and spinal cord and is critical in establishing 
synaptic circuitry during development and in providing for 
synchronous neuronal activity in the adult brain [154–157]. 
Cx36 null mice display functional deficits in various neural 
systems, including visual, motor and memory impairments. 
Electrical synapses are highly dynamic, and, similar to other 
connexins, Cx36 has a half-life of 1–3 h. Cx36 contains a 
PDZ [PSD95, DLGA, zonula occludens-1 (ZO-1)] domain 
interaction motif in its carboxy terminus through which it 
binds to the PDZ domain-containing proteins such as ZO1 
[158].
LNX1 and -2 are RING E3 ubiquitin ligases that have 
multiple roles in the central nervous system. In addition to 
the RING domain, LNX1 and -2 contain four PDZ domains 
through which they interact with their substrate proteins 
[159, 160]. Recently, Nagy and colleagues identified LNX1 
and -2 as important regulators of Cx36 gap junctions in 
neurons [125]. LNX1 and LNX2 were found to partly co-
localize with neuronal gap junctions formed by Cx36 in 
rodent brain, as well as in N2A cells transfected with Cx36-
enhanced cyan fluorescence protein (Cx36-eCFP). In accord-
ance with this finding, as determined by co-immunoprecip-
itation, LNX1 was found to form a complex with Cx36 in 
mouse brain. Through pull-down assays, LNX1 and LNX2 
were found to directly interact with Cx36 via its carboxy 
terminus. Co-transfection of N2A cells with Cx36-eCFP and 
LNX1 caused a strong loss of Cx36-eCFP-containing gap 
junctions, whereas co-transfection with Cx36-eCFP and an 
LNX1 mutant that lacked E3 ubiquitin ligase activity did not 
affect Cx36-eCFP gap junction levels [125]. A similar loss 
of gap junctions was observed in response to overexpression 
of LNX2, whereas a catalytically inactive form of LNX2 did 
not affect gap junction levels. Moreover, LNX2-wt, but not 
a catalytically inactive version, was found to increase Cx36-
eCFP ubiquitination. The LNX2-induced loss of gap junc-
tions was associated with reduced Cx36-eCFP protein levels 
due to increased lysosomal degradation. Collectively, these 
data add Cx36 to the list of substrate proteins of LNX1 and 
-2 in neurons and suggest that ubiquitination has an impor-
tant role in controlling the plasticity of electrical synapses 
formed by Cx36-containing neuronal gap junctions.
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Conclusions and future perspectives
An increasing body of experimental data points toward a 
central role of connexin ubiquitination in the regulation 
of gap junction intercellular communication. The emerg-
ing picture is that connexins can become ubiquitinated at 
different subcellular localizations, such as the endoplas-
mic reticulum, the plasma membrane and endosomes, and 
that at each of these locations, connexin ubiquitination 
may play distinct roles. In accordance with this notion, 
connexins have been demonstrated to be modified with 
different types of ubiquitination. Each of these types of 
ubiquitin modifications of connexins may, in principle, be 
recognized by different effector proteins containing ubiq-
uitin-binding domains that link connexin ubiquitination to 
a specific downstream event, such as proteasomal degra-
dation, endocytosis or lysosomal sorting of connexins. In 
recent years, researchers have also started to shed light on 
the physiological roles of connexin ubiquitination in spe-
cific tissue types and how dysregulation of these processes 
may contribute to loss of functional gap junctions during 
disease pathogenesis.
Among the key challenges ahead is to obtain a more com-
prehensive understanding of the molecular basis by which 
E3 ubiquitin ligases and deubiquitinating enzymes, as well 
as other components of the ubiquitin system, control gap 
junction intercellular communication. The continuous tech-
nological developments in the fields of mass spectrometry 
and proteomics are likely to set the stage for new advances 
in this research area. In the future, it will also be interesting 
to further investigate the cell- and tissue-type specific roles 
of E3 ubiquitin ligases and deubiquitinating enzymes in the 
regulation of gap junctions using relevant mouse knock-out 
and knock-in models. A possible scenario is that the com-
ponents of the ubiquitin conjugation machinery involved in 
controlling connexin ubiquitination and gap junction levels 
vary considerably between different cell types as well as 
between connexin isoforms.
Dysregulation of protein ubiquitination is involved in 
numerous human diseases, including cancer, neurodegen-
erative diseases, and autoimmunity and inflammatory disor-
ders [92]. Components of the ubiquitin system are, therefore, 
attractive drug targets [161]. So far, relatively few drugs tar-
geting the ubiquitin system have been approved for clinical 
use [161]. However, new technical advances, combined with 
an increased knowledge about the ubiquitination process, are 
likely to spur progress in this area of drug development [92, 
161]. As our understanding of the role of ubiquitination in 
the regulation of connexins increases, the development of 
new drugs that target the ubiquitin system could offer novel 
therapeutic opportunities for restoring functional gap junc-
tions in human disease states.
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